High LDL cholesterol in DAA treatment for chronic hepatitis C -Comparative study between each DAA treatment-

Kanzo(2017)

引用 1|浏览5
暂无评分
摘要
We compared the change of real world effectiveness and LDL-cholesterol (LDL-C) value in 4 types of DAA treatment Daclatasvir+Asunaprevir (DCV/ASV), Ledipasvir+Sofosbuvir (LDV/SOF), Paritaprevir/ritonavir+Ombitasvir (PTVr/OBV), Sofosbuvir+Ribavirin (SOF/RBV) for 465 patients with chronic hepatitis C. There were no differences in HCV RNA negative rate and SVR rate of four treatments.
更多
查看译文
关键词
high ldl cholesterol,hepatitis
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要